定量动态增强MR成像初步预测晚期胰腺导管腺癌对吉西他滨为基础化疗的反应
回顾性分析40例经组织学确诊的胰腺导管腺癌患者,采用定量DCE-MRI参数(Ktrans、ve、kep、iAUC60)比较化疗反应者与无反应者。反应者外周、全肿瘤层面及邻近非肿瘤区ROI的Ktrans显著高于无反应者,外周ROI的kep在反应者中显著更高;ve和iAUC60在所有ROI均无显著差异。外周ROI的kep的AUC最高(0.806),但与Ktrans相比无统计学差异。
要点
- 反应者外周、全肿瘤层面及邻近非肿瘤区ROI的Ktrans均显著高于无反应者。
- 反应者外周ROI的kep显著高于无反应者,AUC为0.806。
- ve和iAUC60在所有ROI均不能区分反应者与无反应者。
核心结论
- DCE-MRI定量参数可能是胰腺导管腺癌患者对吉西他滨化疗反应的潜在预测指标。
- 灌注参数因ROI位于不同肿瘤及瘤周区域而存在差异。
研究设计与样本
- 回顾性分析40例经组织学确诊的胰腺导管腺癌患者,均接受定量DCE-MRI检查。
- 按化疗反应分为反应者和无反应者两组,比较不同ROI(外周、全肿瘤层面、邻近非肿瘤区等)的DCE-MRI参数。
诊断标准与关键数值
- 反应者外周ROI的Ktrans显著高于无反应者(P=0.015)。
- 反应者全肿瘤层面ROI的Ktrans显著高于无反应者(P=0.043)。
- 反应者邻近非肿瘤区ROI的Ktrans显著高于无反应者(P=0.025)。
- 反应者外周ROI的kep显著高于无反应者(P=0.013),AUC为0.806,但与Ktrans的AUC相比无统计学差异。
- ve和iAUC60在所有ROI的反应者与无反应者间均无显著差异(P=0.140-0.968)。
临床应用与阅片要点
- 测量DCE-MRI参数时需注意ROI位置,外周、全肿瘤层面及邻近非肿瘤区ROI的Ktrans均显示组间差异。
- 外周ROI的kep的AUC为0.806,但原文指出其与Ktrans的AUC相比无统计学差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To investigate the role of the quantitative parameters of dynamic contrast-enhanced MR imaging (DCE-MRI) in the prediction of the response to chemotherapy in pancreatic ductal carcinoma (PDC).
METHOD: Forty patients with histologically confirmed PDC who underwent quantitative DCE-MRI were retrospectively analyzed. All patients were divided into groups of responders and nonresponders. DCE-MRI parameters, including the volume transfer constant (Ktrans), the extracellular extravascular volume fraction (ve), the rate constant (kep) and the initial area under the concentration curve in 60 s (iAUC60), were measured and compared. DCE-MRI parameters were obtained from different ROIs.
RESULTS: The values of Ktrans in responders with peripheral, whole tumor slice, and adjacent non-tumorous region ROIs were significantly higher than those in nonresponders (P = 0.015, 0.043, and 0.025, respectively). Responders showed a significantly higher kep with peripheral area ROI compared with nonresponders (P = 0.013). Ve and iAUC60 with all ROIs were not significantly different between responders and nonresponders (P = 0.140-0.968). Kep with periphery ROI showed the highest area under the ROC curve (AUC) of 0.806, but there were no statistical differences when compared with values of Ktrans.There were statistically significant differences for DCE-MRI parameters among four ROIs (all P < 0.05). All parameters showed good to excellent intra and interobserver agreement.
CONCLUSIONS: Quantitative parameters derived from DCE-MRI might be a potential predictor of response to gemcitabine in patients with PDC. Perfusion parameters were diverse depending on the location of the ROI on different tumoral and peritumoral areas.
引用
- Tang W, Liu W, Li HM, et al. Quantitative dynamic contrast-enhanced MR imaging for the preliminary prediction of the response to gemcitabine-based chemotherapy in advanced pancreatic ductal carcinoma. Eur J Radiol. 2019. PMID: 31743881. doi:10.1016/j.ejrad.2019.108734
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。